Authors' recommendations: Screening tools may be classified as comprehensive or non-comprehensive. Comprehensive tools evaluate all primary domains of cognitive function, namely memory, language, visuospatial/perceptual processing, attention, and executive functioning. They are reported to be suitable for more specialist level of care. ACE-R and MoCA are two comprehensive tests found to have high accuracies in differentiating mild cognitive impairment from normal controls. However, their ability to distinguish MCI from early Alzheimers dementia was not examined. Non-comprehensive screens examine only a limited number of domains and may be more suited to general practice. In this report, DemTect and M@T are as examples of non-comprehensive tools that can differentiate MCI from NC. M@T, but not DemTect, has the additional ability to differentiate MCI from AD with high accuracy. Both the Qmci and QCST are reported to require a very short time to administer and score. They have the ability to differentiate between MCI and NC as well as between MCI and mild AD. Currently there is no consensus on a single most accurate screening tool for MCI.

Project Status: Completed

Year Published: 2013

URL for published report: http://www.cadth.ca/media/pdf/htis/sep-2013/RC0475_Mild%20Cognitive%20Impairment%20Final.pdf

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Canada

Organisation Name: Canadian Agency for Drugs and Technologies in Health

Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;

Contact Name: requests@cadth.ca

Contact Email: requests@cadth.ca

Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)